Best Weight Training Program
Share
The best strength training program to prevent sarcopenia during GLP‑1 therapy is a structured, progressive resistance training regimen that emphasizes compound movements, adequate volume, and proper recovery, paired with optimal protein intake.
For beginners, start with full-body resistance training sessions two to three times per week, focusing on compound exercises such as squats, hip hinges (deadlifts), pushes (bench press, push-ups), and pulls (rows, pull-downs). Aim for 2–3 sets of 10–12 repetitions at 60–70% of your one-repetition maximum (1RM), with a focus on proper form and neuromuscular adaptation. Controlled eccentric movements (2–3 seconds) maximize muscle activation and time under tension.
Intermediate lifters can benefit from higher intensities, typically 70–85% of 1RM, with 2–4 sets per movement and a frequency of 3–4 sessions per week, allowing 48–72 hours of recovery for each muscle group. Progressive overload and periodization—alternating hypertrophy and strength-focused blocks—further optimize muscle retention.
Protein intake is crucial: aim for 1.2–1.6 grams of protein per kilogram of body weight daily, distributed evenly across meals (20–40g per meal) to maximize muscle protein synthesis. Liquid protein supplements (whey, Greek yogurt, shakes) are useful if solid food is unappealing due to medication side effects.
A well-rounded program also includes aerobic exercise (walking, cycling, swimming) for 150 minutes of moderate-intensity activity per week, which supports overall metabolic health and complements strength training. For older adults or those with preexisting sarcopenia risk, conservative progression and fall-risk screening are essential.
Studies show that combining resistance training with GLP‑1 therapy results in greater fat loss and better preservation of lean mass compared to medication alone. Regular, tailored strength training is a vital part of preventing sarcopenia and maintaining functional independence during GLP‑1 therapy
AGE AND TRAINING MATTERS
For older adults on GLP‑1 therapy, the recommended resistance training frequency is 2–3 sessions per week, with each session focusing on major muscle groups using compound exercises such as squats, deadlifts, push-ups, and rows. Each session should include 2–4 sets per exercise, with 8–10 exercises targeting large muscle groups, performed at an intensity of 50–80% of one-repetition maximum (1RM) to balance effectiveness and safety.
Volume should be progressive: beginners can start with 10–15 repetitions per set, gradually advancing to 3 sets of 8–10 repetitions as strength and tolerance improve. Shorter sessions of 30–45 minutes are often better tolerated, especially for those experiencing medication-related fatigue or GI symptoms. Controlled eccentric movements (2–3 seconds per rep) maximize muscle activation and time under tension, which is especially important for muscle retention in older adults.
It is crucial to allow 48–72 hours of recovery between sessions for each muscle group to prevent overtraining and support muscle repair. Regular monitoring for signs of poor recovery—such as prolonged muscle soreness, decreased performance, or increased fatigue—is essential, and programs should be adjusted as needed to promote long-term consistency.
In summary, older adults on GLP‑1s should aim for 2–3 weekly resistance training sessions, 2–4 sets per exercise, and 8–10 compound movements per session, with intensity and volume adjusted for individual experience and tolerance. This approach helps preserve lean mass, maintain functional independence, and reduce sarcopenia risk during GLP‑1 therapy.
PRESERVING LEAN MASS
Evidence consistently shows that higher frequency of resistance training is strongly linked to the preservation of lean mass in individuals on GLP‑1 therapy. Systematic reviews and meta-analyses report that patients who engage in regular resistance training—typically 2–3 sessions per week—experience less lean mass loss compared to those who do not exercise or only perform aerobic activities. For example, one meta-analysis found that resistance training combined with GLP‑1 therapy reduced lean mass loss to about 25% of total weight loss, compared to up to 40% in sedentary patients.
Studies also indicate that the combination of resistance training and high protein intake is the most effective approach for minimizing lean mass loss during GLP‑1–induced weight loss. In clinical trials, patients who maintained regular resistance exercise throughout their treatment preserved lean mass more effectively and maintained greater fat loss, leading to improved body composition and functional outcomes. One study demonstrated that supervised exercise combined with GLP‑1 therapy preserved lean mass and improved body composition significantly better than GLP‑1 therapy alone after one year.
Moreover, research shows that the adaptive response of muscle to GLP‑1 therapy is enhanced by consistent resistance training, which helps maintain muscle quality, strength, and function even as overall weight decreases. The most robust protection against sarcopenia is seen in patients who follow a structured resistance training program throughout their treatment, rather than those who exercise sporadically or not at all.
In summary, the evidence strongly supports regular resistance training (2–3 sessions per week) as a key factor in preserving lean mass during GLP‑1 therapy, especially when combined with adequate protein intake and consistent monitoring
Speak to our Weight Loss experts
If you're struggling with weight loss and are looking for a compound GLP-1 solution with physician oversight, book an appointment with our weight loss health specialists by calling us at (831) 232-9413 or filling out our online form HERE.
Complete our Weight Loss online survey HERE to see if you are a good GLP-1 candidate or by calling (831) 232-9413.
Download our weight loss guide HERE for more information on how to safely navigate GLP-1 weight loss.
